IFN migliora outcome di HCC trattato

Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma. Singal AK, Freeman DH Jr, Anand BS. Aliment Pharmacol Ther. 2010 Oct;32(7):851-8.  SUMMARY: Background Hepatocellular carcinoma (HCC) is third most common cause of tumour-related death in the US with hepatitis C virus (HCV) the most common aetiology. Surgical resection and tumour ablation are curative…

H.p.e rischio di sanguinamento GI in pz che assumono ASA

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin. Fletcher EH, Johnston DE, Fisher CR, Koerner RJ, Newton JL, Gray CS. Aliment Pharmacol Ther. 2010 Oct;32(7):831-9.  SUMMARY: Background Aspirin is widely used to modify the risk of recurrent vascular events. It is, however, associated with increased upper gastrointestinal…

RCT sulla preparazione intestinale

Efficacy of morning-only compared with split-dose polyethylene glycol electrolyte solution for afternoon colonoscopy: a randomized controlled single-blind study.Matro R, Shnitser A, Spodik M, Daskalakis C, Katz L, Murtha A, Kastenberg D.Am J Gastroenterol. 2010 Sep;105(9):1954-61. Epub 2010 Apr 20. AbstractOBJECTIVES: Administering a purgative close to the time of colonoscopy is optimal for cleansing. The aim of…

NICE guideline: Ablative therapy for the treatment of Barrett’s oesophagus

Ablative therapy for the treatment of Barrett’s oesophagus ( NICE guideline) This clinical guideline offers evidence-based advice on the care and treatment of adults having ablative therapy to treat Barrett’s oesophagus with high-grade dysplasia or with intramucosal cancer. It is the full guideline and contains all the recommendations, details of how they were developed, and reviews…